Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cornelia Handl

1PUBLICATIONS

13CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 04, 2025

Mosperafenib, a Novel Paradox-Breaker BRAF Inhibitor with Potent Preclinical Activity in BRAF-Mutated Colorectal Cancer.

Florian Renner, Jan Eckmann, Cornelia Handl

Pageof 1

Frequent Collaborators

1 joint publications

Florian Renner

1 joint publications

Jan Eckmann

1 joint publications

Jürgen Wichmann

1 joint publications

Gabriel Schnetzler

1 joint publications

Nicole A Kratochwil

1 joint publications

Nino Keshelava

1 joint publications

Javier Ros

1 joint publications

Elena Élez

1 joint publications

Jordi Vergés

1 joint publications

Irene Chicote

Frequent Collaborators

1 joint publications

Florian Renner

1 joint publications

Jan Eckmann

1 joint publications

Jürgen Wichmann

1 joint publications

Gabriel Schnetzler

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos